Fingerprint
Dive into the research topics of 'Phase I dose escalation trial of weekly docetaxel plus irinotecan in patients with advanced cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Eric Bleickardt, Athanassios Argiris, Randy Rich, Kathi Blum, Anne McKeon, Harold Tara, Daniel Zelterman, Barbara Burtness, Marianne J. Davies, John R. Murren
Research output: Contribution to journal › Article › peer-review